Aurora Cannabis Inc. Common Shares (ACB)
ACB trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 40-F (ifrs-full:RevenueFromContractsWithCustomers), period ending 2025-03-31, https://www.sec.gov/Archives/edgar/data/1683541/000168354125000008/0001683541-25-000008-index.htm. Net income: SEC 40-F (ifrs-full:ProfitLoss), period ending 2025-03-31. Converted from CAD at 1.4219 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | ACB on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001683541 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | A1 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $241.4M |
| Net income | $1.1M |
| Operating income | Not in SEC XBRL data |
| Net margin | 0.5% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | 237.5× |
| P/S (computed) | 1.1× |
Reported in CAD; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2026-06-11 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-14 |
Source: SEC EDGAR submissions feed, 424 recent filings. All filings on EDGAR.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SNDL | SNDL Inc. Common Shares | $1.16 | -0.85% | $285.5M |
| USNA | USANA Health Sciences Inc. | $15.46 | +3.41% | $285.6M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| OBIO | Orchestra BioMed Holdings Inc. | $5.72 | -3.21% | $343.8M |
| NAGE | Niagen Bioscience Inc. | $2.58 | -1.90% | $204.1M |
| MDWD | MediWound Ltd. | $12.22 | -2.71% | $157.8M |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier